Renovus Capital Partners Majority Investment in ToxStrategies
January 24, 2023
Renovus Capital Partners made a majority investment in ToxStrategies, a multidisciplinary scientific consulting firm specializing in toxicology, epidemiology, exposure sciences and regulatory compliance. Five Points Capital provided debt and equity co-investment to support the transaction; terms were not disclosed and the deal was described as a recapitalization to support growth and expand services, staff and geographic reach.
- Targets
- ToxStrategies
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
ToxStrategies Acquires Suttons Creek
August 13, 2024
Healthcare Services
ToxStrategies, a Renovus Capital Partners portfolio company, has acquired Suttons Creek to expand its combination-product development and regulatory consulting capabilities. Brookside Capital Partners provided financing to support the add-on acquisition; Suttons Creek will operate as a division of ToxStrategies and its founder Steven Badelt will continue to lead the business. Terms were not disclosed.
-
ToxStrategies Acquires Clintrex Research Corporation
June 25, 2024
Healthcare Services
ToxStrategies, a Renovus Capital Partners–backed scientific consulting firm based in Katy, Texas, has acquired Clintrex Research Corporation, a Sarasota-based clinical and regulatory development services provider focused on neurodegenerative and CNS therapies. The deal (terms undisclosed) expands ToxStrategies' clinical, regulatory, biostatistics and drug‑development capabilities and is intended to broaden its end‑market reach in the life sciences sector.
-
ToxStrategies (Renovus-backed) Acquires Modality Solutions
August 8, 2023
Healthcare Services
ToxStrategies, a Renovus Capital Partners-backed life sciences consulting platform, has acquired Modality Solutions, a Houston-based firm specializing in biopharmaceutical cold-chain optimization and shipping validation testing. The add-on expands ToxStrategies' cold-chain, package engineering, and regulatory testing capabilities and will operate as a division of ToxStrategies with Modality's founders continuing to lead the business.
-
Renovus Capital Partners Invests in Thomas J. Paul, Inc.
January 16, 2023
Marketing & Advertising
Renovus Capital Partners has made a majority investment in Thomas J. Paul, Inc. (TJP), a Pennsylvania-based healthcare and consumer marketing communications firm specializing in payer marketing, market access, and patient affordability programs. Renovus will partner with TJP's management and owner Jim Paul to broaden the company's market access offerings and support growth initiatives.
-
Renovus Capital Partners Invests in SolomonEdwards
April 20, 2022
Professional Services
Renovus Capital Partners has made a significant growth capital investment in SolomonEdwardsGroup, LLC, a national professional services firm focused on strategy execution. The capital will be used to invest in the team and delivery capabilities and to accelerate SolomonEdwards' expansion as a platform company.
-
Renovus Capital Partners Makes Growth Investment in Thought Logic Consulting
February 7, 2021
Consulting
Renovus Capital Partners has made a growth capital investment in Thought Logic Consulting to support the firm's investments in its team and capabilities, accelerate planned geographic expansion, and pursue industry partnerships and acquisitions. Thought Logic, a business and technology transformation consultancy with offices in Atlanta, GA and Richmond, VA, will leverage Renovus' experience in scaling founder-led services businesses.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.